GlassScriptPhysician profile
Sheryl Arlynn Wilson
NPI 1629350160
$1,007.39
in general payments reported to CMS, 2019-2025
8 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $296 · 2023: $78.66 · 2024: $258 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378 · Education: $98.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.38 |
| Education | $98.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $423.32 | 2021-2023 | |
| Pharming Healthcare, INC. | $131.04 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.02 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $98.35 | 2024 | Dupixent |
| Lilly USA, LLC | $95.37 | 2021-2023 | Taltz, Olumiant |
| Coloplast Corp | $65.86 | 2022 | |
| Incyte Corporation | $51.01 | 2023-2025 | Opzelura |
| Genentech USA, INC. | $28.42 | 2024 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheryl Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.